Valsartan
Product Images NDC 45865-101

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Valsartan (NDC 45865-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp_101 (Pdp 101)

Description: This is a label for a container of Valsartan tablets. The details include the dosage (80mg), the manufacturer (Sjubricant Generics Ltd), and precautions to be taken before using the product.*

FDA Label Image

Figure01 (Fig01)

This is a clinical study that compares the effectiveness of Valsartan and Captopril in treating patients. The study evaluates subgroups such as age (<65 years old and 65+), gender (male and female), ethnicity (Caucasian and non-Caucasian), country of origin (US and Non-US), and usage of Beta-blocker. The effectiveness of each medication is reported in percentage, with Favors Valsartan being more effective in some cases and Favors Captopril being more effective in others.*

FDA Label Image

Structuralformula (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.